CBIO

Crescent Biopharma

80 hedge funds and large institutions have $123M invested in Crescent Biopharma in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

26% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 31

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.9M
Puts
$263K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$27.9M
2
$22.2M
3
$11.4M
4
$11.3M
5
$9.01M
6
$7.67M
7
$5.39M
8
$3.67M
9
$2.06M
10
$1.86M
11
$1.53M
12
$1.38M
13
$1.32M
14
$1.25M
15
$1.05M
16
$999K
17
$941K
18
$937K
19
$896K
20
$782K
21
$707K
22
$642K
23
$612K
24
$549K
25
$458K